Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 27, 2023 at 09:00 am EDT
Share
Farmacias Benavides, S.A.B. de C.V. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was MXN 4,198.45 million compared to MXN 3,984.3 million a year ago. Net income was MXN 48.64 million compared to MXN 69.37 million a year ago. Basic earnings per share from continuing operations was MXN 0.118962 compared to MXN 0.169671 a year ago.
For the nine months, sales was MXN 12,723.62 million compared to MXN 11,839.63 million a year ago. Net income was MXN 224.33 million compared to MXN 125.24 million a year ago. Basic earnings per share from continuing operations was MXN 0.548683 compared to MXN 0.306332 a year ago.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
FARMACIAS BENAVIDES, S.A.B. DE C.V. 
